4.98 -0.17 (-3.3%) | 06-21 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 6.76 ![]() |
1-year : | 7.59 |
Resists | First : | 5.79 ![]() |
Second : | 6.5 |
Pivot price | 5.62 ![]() |
|||
Supports | First : | 4.65 ![]() |
Second : | 3.86 ![]() |
MAs | MA(5) : | 5.42 ![]() |
MA(20) : | 5.71 ![]() |
MA(100) : | 6.16 ![]() |
MA(250) : | 6.54 ![]() |
|
MACD | MACD : | -0.2 ![]() |
Signal : | -0.2 ![]() |
%K %D | K(14,3) : | 10.1 ![]() |
D(3) : | 20.1 ![]() |
RSI | RSI(14): 28.8 ![]() |
|||
52-week | High : | 8.98 | Low : | 4.65 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PRPO ] has closed below the lower bollinger band by 13.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 10.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 5.1 - 5.13 | 5.13 - 5.16 |
Low: | 4.56 - 4.61 | 4.61 - 4.64 |
Close: | 4.91 - 4.98 | 4.98 - 5.03 |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Fri, 21 Jun 2024
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average of $6.21 - Defense World
Sun, 16 Jun 2024
PRPO - Precipio, Inc. Latest Stock News & Market Updates - StockTitan
Wed, 12 Jun 2024
Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future - Yahoo Canada Sports
Wed, 12 Jun 2024
Precipio Provides Status Update on Current Business Matters - StockTitan
Fri, 07 Jun 2024
Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet - Simply Wall St
Fri, 07 Jun 2024
It's Probably Less Likely That Precipio, Inc.'s (NASDAQ:PRPO) CEO Will See A Huge Pay Rise This Year - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Diagnostics & Research
|
|
Shares Out | 1 (M) |
Shares Float | 1 (M) |
Held by Insiders | 6.1 (%) |
Held by Institutions | 8.2 (%) |
Shares Short | 2 (K) |
Shares Short P.Month | 5 (K) |
EPS | -3.36 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 8.93 |
Profit Margin | -31 % |
Operating Margin | -60.5 % |
Return on Assets (ttm) | -23.2 % |
Return on Equity (ttm) | -36.4 % |
Qtrly Rev. Growth | 21.7 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 10.75 |
EBITDA (p.s.) | -3.66 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -3 (M) |
Levered Free Cash Flow | -2 (M) |
PE Ratio | -1.49 |
PEG Ratio | 0 |
Price to Book value | 0.55 |
Price to Sales | 0.46 |
Price to Cash Flow | -2.77 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |